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Background: The volume and outcome relationship for transplant procedures has become one of the major
topics during discussions about consequences following the organ transplantation scandal of wait-list manipulations
in Germany during the past year. Proponents of reducing the number of centers argue in favor of increasing
quality at highly specialized transplant centers while disregarding the wish of patients for regionally available
medical service.
Methods: The homepage of the German Organ Procurement Organization (DSO) was screened for the annual
reports of transplant programs for the years 2007 to 2010. Results were extracted from these reports.
Additionally, an analysis of volume per million people per number of transplant centers for each German federal
state was made to give an overview of the density of transplant programs for the years 2009 to 2011.
Results: In-house mortality (R2 = 0.005, P = 0.518), 3-year survival (R2 = 0.068, P = 0.085), and a ROC analysis for
in-house mortality (AUC 0.55, CI: 0.41; 0.68, P = 0.53), did not show volume-outcome relation. Definition of a
threshold for good centers was impossible. One-year survival indicated better outcome in high volume centers.
R2 = 0.106, P = 0.009. Outcome data in Germany, as provided by Institute für angewandte Qualitätsförderung und
Forschung im Gesundheitswesen (AQUA) or the DSO, are not risk adapted for the investigated time period. The factor
of transplants per year per million people per transplant centers is 0.6 for Germany. Some Federal States (for example,
Bavaria and Northrhine Westfalia) have an oversupply of transplant centers, which means that the average
number transplanted per center and year is very low.
Discussion and conclusion: We propose a risk-adapted prospective analysis of outcome and definition of a quality
catalogue for liver transplant centers. Volume and outcome relation is not conclusive for liver transplantation in
Germany. Data should be collected, for example, for a time period of 3 to 5 years, and decisions influencing the
regulation of numbers of transplant centers should be based upon the findings, weighing federal state sovereignty
and regional medical requirements against an optimal patient supply while respecting a plausible risk adaption for each
center.Introduction
The German transplant scandal in 2012, which uncov-
ered several centers with wait-list manipulations indicat-
ing higher than actual urgency in patients, unleashed a
variety of controversies and debates on the current sys-
tem of organ transplantation. Among very reasonable
and politically important topics, like the discussion of
the current organ allocation system, self-administration* Correspondence: andreas.schnitzbauer@kgu.de
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reproduction in any medium, provided the orand transparency in maintenance of wait lists as estab-
lished in Germany and represented by the German Med-
ical Association and the call for more governmental
control, there were also strong voices that demanded a re-
duction of the currently 24 centers performing liver trans-
plantations in Germany. One of the leading arguments for
reducing the number of centers was an increasing quality
of liver transplantation by focusing on centralization on a
small number of high-volume centers. Although, some
evidence for volume-outcome relation has been shown for
various surgical fields, including liver transplantation, it is
quite difficult and challenging to define proper thresholds
for the size of ‘good’ transplant centers [1]. Moreover, theLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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confounding and bias-factors that may draw a misleading
picture [1,2]. Opponents of closing down small transplant
centers argue with the right for a regional medical supply
for all patients in times of extreme rationalization and
compression of medical treatment in particular areas of
Germany. Proposals of centers delivering good outcome
range between 20 to 50 liver transplants per year. In order
to lift this element of the current debate from a perceived
level of evidence to a level with resiliently arguable data
based on the best available information, we performed an
analysis of in-house mortality, 1- and 3-year survival
analysis from annual reports of the German Organ
Procurement Organization (DSO) in relation to the
volume of transplant centers in Germany for the years
2007 to 2010.
Methods
Data source and extraction of data
To receive data for each liver transplant center, the
homepage of the Deutsche Stiftung für Organtransplan-
tation (DSO) was screened for the annual reports of
transplant programs for the years 2007 to 2010 [3]. From
these reports the results for every individual liver
transplant program in Germany were extracted as pub-
lished in the report under point 1.5 in ‘results of trans-
plantation’. Data collected were: 1) patients reported
and in-house mortality, 2) 1- and 3) 3-year mortality
rates of the patients reported to the DSO in the par-
ticular years, and 4) total number of patients trans-
planted. In cases where five or fewer patients were
reported to the DSO, the number of patients was set to
five since an exact number of patients reported was
not documented in the reports for data safety protec-
tion regulations.
Moreover, cumulatively presented data for the years
2009 to 2012 were collected from the annual reports for
liver transplantation, which are published by the AQUA
institute, the organization that is officially responsible
for quality control in liver transplant programs. These
data were available from the homepage (https://www.sqg.
de/ergebnisse/leistungsbereiche/lebertransplantation.html)
and were compared to the data from the DSO to deter-
mine consistency of the data extracted from the DSO
homepage.
Additionally, an analysis of volume per million people
per number of transplant centers for each individual
German federal state was made to give an overview of
the concentration and density of transplant programs in
each particular state. Data of the number of liver trans-
plantations from deceased donors for the years 2009 to
2011 were extracted from the DSO homepage (http://
www.dso.de/medien-und-presse/pressebilder-und-grafiken.
html). The number of people living in each federal statewas extracted from the homepage of the Federal Office of
Statistics in Germany.
Analysis
In-house mortality and 1- and 3-year survival data were
analyzed descriptively. Data are given as the mean with
standard deviation and median with ranges along with
95% confidence intervals (95% CI). Linear regression
analyses, analogous to the analysis of Edwards et al.,
were performed to identify a correlation of survival and
size of the transplant centers [4]. R2 values (Pearson cor-
relation) and levels of significance (P values) were
depicted and interpreted. Nonlinear regression analysis
was performed for in-house mortality with a polynomial
cubic equation via dynamic fitting to exclude signifi-
cance with another model. Additionally, for in-house
mortality, a receiver operating characteristic (ROC) ana-
lysis was performed, assuming that an in-house mortality
of less than 20% is acceptable as demanded in the annual
quality definitions for liver transplantation of AQUA
(Institut für angewandte Qualitätsförderung und For-
schung im Gesundheitswesen, Göttingen, Germany).
Data are given as area under the curve (AUC) with 95%
CI and significance levels. The outcome for volume per
million people per number of transplant centers in the
individual federal states in Germany was given as a fac-
tor. Statistical analysis was performed with SPSS™ Ver-
sion 20 (IBM, Armonk, New York, USA).
Results
Completeness and quality of data
For a total of 3,317 patients, in-house mortality rates
were reported whereas a total of 4,316 patients were re-
ported as transplanted in the investigated 3-year period.
This resulted in a reporting rate of 76.9% of patients,
reflecting the large variety of the quantity of reported data
in the investigated time period between 2007 and 2010.
Notably, quality control of liver transplant programs does
not distinguish between transplantation from deceased
donors, living-related liver transplantations, pediatric liver
transplantation or split-liver transplantation, so far. Infor-
mation on the number of re-transplantations was also not
available.
In-house mortality
A total of 79 (82%) of 96 datasets (1 report per center
per year from 24 centers) reporting in-house mortality
were available for the years 2007 to 2010. A total of 24
transplant centers reported their results to the DSO.
The mean in-house mortality was 17.6 ± 11.3% (range: 0
to 71.4%). The German institute for quality control
AQUA defined an in-house mortality of ≤20% as accept-
able. In-house mortality >20 percent precipitated queries
for explanations of mortality from the particular center
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AQUA. Figure 1 shows an equally distributed cloud dia-
gram around the 20% in-house mortality line for small
centers (but reporting more than five liver transplants
per year) as well as for larger centers. This is supported
by the ROC-analysis (AUC 0.55, CI 0.41; 0.68, P = 0.53)
displayed in Figure 2, delivering no clinically significant
cut-off value for the volume of a transplant center that
impacts transplant outcome positively or negatively. Not-
ably, there are a large number of centers that reported five
patients or fewer, although officially performing much
higher numbers of liver transplants. The number of cen-
ters performing fewer than 20 liver transplants per year
was stable over the years, ranging between 4 and 8 (16.7
to 33.3%) centers.
One- and three-year patient survival
For 1-year survival data a total of 64 (67%) of 96 datasets
were reported to the DSO. One-year overall mean sur-
vival was 73.2 ± 16.8% (range: 0 to 100%). Figure 3 shows
a cloud diagram with an equal distribution for transplant
centers reporting more than five transplants per year.
Three-year survival was reported with a mean of 66.0 ±
18.4% (range: 0 to 100%) reflecting a trend for better
outcome in sites transplanting more than 30 livers per
year (Figure 4). However, this finding is based on 45
(47%) of 96 datasets received during the investigated
period.
Linear regression analysis comparing outcome and
volume
Regression analysis for in-house mortality (r2 = 0.007,










Figure 1 In-house mortality for German liver transplant centers per centdelivered no significant correlation between center vol-
ume and outcome. However for 1-year-overall survival, a
better outcome was significantly correlated with larger
center size (r2 = 0.09, P = 0.009). Nonlinear regression, as
mentioned in the methods section, did not reveal a signifi-
cant relationship between parameters for in-house mortal-
ity (P = 0,257).
Consistency check of results comparing DSO data with
AQUA institute data
A critical review of the findings of our analysis suggests
that data quality may cause a significant bias. Therefore,
overall quality data from the AQUA institute were
excerpted from the annual reports as a consistency
check. The completeness of reported datasets to the
AQUA institute for the years 2009 to 2012 was between
96 and 103% for all liver transplant programs in Germany
as outlined in their reports. The median in-house mortal-
ity for centers performing fewer than 20 liver transplants
per year was similar to that for centers with more than 20
transplants per year, reaching less than 20% in-house mor-
tality. Similar data were published for 1-year survival of
patients who did not experience in-house mortality. In
both groups, regardless of the number of transplants
performed, the average 1-year survival rate censored
for in-house mortality was between 90 and 93% for the
years 2009 to 2012.
Transplant volume per million people per transplant
center
There were 3,413 liver transplants from deceased donors
in Germany between 2009 and 2011, which is an average
of 1,137 transplants per year performed at 24 transplantatients reported
er per year including linear regression analysis. R2 = 0.005, P = 0.518.









Figure 3 One-year survival for German liver transplant centers per center per year including linear regression, indicating better
outcome in high volume centers albeit reduced quality of data. R2 = 0.106, P = 0.009.
Figure 2 Receiver operating characteristics (ROC)-analysis for in-house mortality without delivering a threshold, indicating a volume
outcome relation. (AUC 0.55, CI: 0.41; 0.68, P = 0.53).
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Figure 4 Three-year survival for German liver transplant centers per center per year including linear regression, indicating no relation
between volume and outcome albeit reduced quality of data. R2 = 0.068, P = 0.085.
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scriptively calculated, the annual number of transplants
per million people per transplant centers is 0.6 in
Germany. However, when calculated as the number of
transplants per million people per transplant centers in
each individual state, results become clearer and depict
a representative density of regional medical supply. Con-
sidering these calculations, there are regions with fewer
than 5 transplants per million people per transplant
centers (Bavaria, Northrhine-Westfalia, Mecklenburg-
Western Pomerania) and other regions between 5 and
15 transplants per million people per transplant cen-
ters (Baden-Wurtemberg, Hesse, Lower Saxony, Rhineland-
Palatinate, Saxony-Anhalt, Schleswig Holstein/Hamburg)
and those with more than 15 transplants per million
people per transplant centers (Berlin/Brandenburg,
Saarland, Saxony, Thuringia) (Table 1). Excluded from
our consideration was a certain patient traffic from
one federal state to the other, especially in adjacent re-
gions or over-regionally active sites, who recruit their
patients from all over Germany. Nonetheless, when
comparing the numbers with data from the United
Kingdom (UK) (as outlined in the discussion), data ap-
pear to be consistent, comparable and conclusive.
Discussion
The relation of volume and outcome for German liver
transplant centers cannot be conclusively and satisfac-
torily determined. Data provided by the DSO, as well as
by the AQUA institute, are not strikingly significant for
all years analyzed. There are several reasons for this con-
clusion. First, the quality of reported data is moderatewith completeness of datasets reaching only 82% for in-
house mortality and less for 1- (67%) and 3- (47%) years
overall survival for the years 2007 and 2010. To receive
a clear picture a 100% quality assurance is necessary.
Otto et al. indicated this discrepancy and problem earl-
ier, in 2011, when they drew a worst-case and best-case
scenario for 1-year survival data after liver transplant-
ation. For the year 2009 a 1-year survival of 76.1% was
reported by the AQUA institute. However, the status of
165 out of 964 patients was unknown, resulting in a
best-case scenario (all patients with unknown status
alive) of 80.2% and a worst-case scenario (all patients
with unknown status dead) of 63.1% [5]. The current
situation in Germany is that the AQUA institute de-
mands 100% data reports and paints a worst-case sce-
nario in case of missing data, indicating lower quality for
noncompliant centers. However, data from the AQUA
institute, as outlined in the results section for the years
2009 to 2012, also did not reveal noticeably better re-
sults - except for 1-year survival in 2012 - for larger cen-
ters with a data quality ranging between 96 and 100%
for the investigated years. Therefore, our findings are
consistent albeit data quality for individual centers from
the DSO-homepage is moderate.
Second, results for pediatric and adult liver transplant-
ation are reported as one collective, although results
vary significantly, reaching 1-year survival rates of 90 to
95% for pediatric liver transplant recipients [6]. This
leads to a possible bias in the interpretation of better re-
sults from centers that perform pediatric and adult liver
transplantation. For Germany, results of adult trans-
plantation are inferior to data from other countries: a
Table 1 Overview of liver transplant centers per federal states and the number of transplants per million
Federal State Population
in Million




of centers2011 2010 2009
Bavaria 12.6 5 (4 in 2009) (Munich (2), Regensburg,
Erlangen, Würzburg)
156 166 152 2.7
Baden-Wuertemberg 10.8 2 (Heidelberg, Tübingen) 134 135 145 6.5
Berline/Brandenburgf 6.0 1 (Charité Berlin) 93 102 116 17.3
Hesse 6.1 1 (Frankfurt/Main) 29 46 37 6.1
Mecklenburg-Western
Pomerania
1.6 1 (Rostock) 5 5 0 2.1
Lower Saxonyb/Bremena 7.9 2 (Hannover, Göttingen) 112 145 139 8.4
Northrhine Westfalia 17.8 5 (4 in 2009) (Essen, Aachen, Münster,
Cologne, Bonn)
260 230 214 2.8
Rhineland-Palatinate 4.0 1 (Mainz) 43 43 42 10.8
Saarland 1.0 1 (Homburg) 15 31 9 18.0
Saxony 4.1 1 (Leipzig) 97 85 79 21.2
Saxony-Anhalt 2.3 1 (Magdeburg) 20 19 7 6.5
Schleswig-Holsteind/Hamburgc 4.6 2 (Hamburg, Kiel) 118 107 125 12.7
Thuringia 2.2 1 (Jena) 49 56 47 23.2
People per number of transplant centers for each individual state/region in Germany. Bremena, having no own medical faculty was added to Lower Saxonyb.
Hamburgc and Schleswig Holsteind as well as Berline and Brandenburgf were combined to one major region each.
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matically worse outcome for liver transplant recipients
in the model for end-stage liver disease (MELD) era with
declining results in the MELD >30 group [7]. More than
40% of all patients are transplanted in a status of high
urgency or with a MELD >30 in Germany [8,9]. The
rules apply uniformly for all centers in the same way.
Moreover, results are not risk adapted for indications.
There may be several centers that perform more trans-
plantations with a higher risk and known inferior out-
come after liver transplantation, such as patients with
hepatitis C virus (HCV) cirrhosis. Other centers may
perform more split liver procedures or accept more
extended criteria donors and therefore utilize ‘un-
wanted organs’, which should also be acknowledged in
a risk-adapted outcome report. In our opinion, and in
accordance with UNOS-practice, results for pediatric
and adult liver transplant programs should be reported
separately from each other and should additionally be
presented in a raw and risk adapted fashion. Notably,
in this analysis, split procedures and living related
transplantations (10% per year) were constant and not
considered separately in this analysis.
Our analysis did not deliver a statistically meaningful
cut-off value for the size of a liver transplant program
that is directly associated with beneficial outcome. How-
ever, regression analysis indicated a volume and outcome
relation for 1-year overall survival when transplant cen-
ters performed a higher number of liver transplants.
This was confirmed by the AQUA institute analysisproviding good to very good data quality and especially
showing a more beneficial outcome for larger centers at
1 year after transplantation in 2012. General recommen-
dations for the minimum size of liver transplant centers
for providing satisfying outcome vary between 20 and 50
liver transplants per year [4,10,11]. However, there is a
broad consensus that scientific reports simply correlat-
ing volume and outcome (= survival) are very vulnerable
to confounding factors and that variations in results be-
come large and very difficult to interpret [2].
A more specific look into existing literature assists in
overcoming the pure one-dimensional approach to vol-
ume and outcome relation. Northup et al. analyzed
9,909 adult liver transplant recipients who were trans-
planted in the United States (US) after introducing
MELD-allocation. They concluded that there is no lon-
ger a volume outcome relation for US liver transplant
centers. Raw mortality was lower at large centers. But
when factors like disease severity and donor and recipi-
ent factors were introduced (= risk adaption), the signifi-
cance was no longer present between low and high
volume liver transplant centers [12]. This means that by
selection of recipients as well as donors, results - even at
smaller sites - may be beneficial for patients requiring a
life saving liver transplantation. Vice versa, high volume
centers that accept more extended donor criteria organs
can obtain satisfying results in their patients and thus
utilize the whole available donor pool [13]. Especially for
areas in which high-end medical supply is of reduced
local availability compared to metropolitan areas, this
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care for the majority of people in forms of smaller trans-
plant centers, which have proven that they can also be
successful [11].
To explain this in a more detailed fashion, we analyzed
the number of transplants per million people per num-
ber of liver transplant centers. In Germany this factor is
0.6, which is less than half compared to the UK with 1.5.
In the United Kingdom, numbers of liver transplant cen-
ters are limited to currently 7 sites performing 642 liver
transplants for 63 million people in 2011 [14]. The fac-
tors for each individual region range between 3.6 and
12.8 transplants per million people per number of cen-
ters in a region, with only one single region performing
less than 5 transplants per year per million people. In
Germany there are regions that have five (Bavaria and
Northrhine Westfalia) liver transplant centers with fac-
tors of 2.7 and 2.1 in the regional supply. Other centers
reach factors of 6.5 to 23.2. However, reasons for low
factors may be that there are too many transplant cen-
ters for too few people or too few liver transplants by
single centers in a region with many people. The current
situation, however, seems to uncover a heterogeneity in
the regional plans of supply with liver transplantations
throughout Germany, perhaps owing to the still presti-
gious and also financially relevant factor for hospitals to
run even small transplant programs in highly competi-
tive federal states. Single federal states (for example,
Baden-Wurtemberg and Hesse), in whose hands the
hospital requirement plan generally is placed by law, de-
cided to limit the number of their liver transplant cen-
ters years ago. In other regions, the existence of a single
University Hospital - with general ability of providing
the required infrastructure to run a liver transplant pro-
gram - do not face the problem of competing institu-
tions within a Federal State. Other federal states, such as
Bavaria or Northrhine-Westfalia, have not yet regulated
the number of transplant centers.
Conclusion
There has to be a consistent and persisting definition of
quality for German liver transplant programs that will
allow actions on liver transplant centers in case of fail-
ure. We propose the definition of a quality catalogue
that includes accuracy of reporting to AQUA, success
rate represented by 1-year patient and graft survival data
[15], incidence of re-transplantations and audit results.
Certification of centers with an evaluated minimum
standard infrastructure, structured education of trans-
plant specialists and reconsideration of budgeting of
transplant medicine are further important steps that
need to be accomplished. A data basis for a time period
of, for example, 3 to 5 years, should be collected pro-
spectively and decisions based upon the findings. Risk-adaption of confounding factors should be performed to
present a clearer picture of outcome quality. By this
strategy, of balancing urgency and success as defined in
the German transplant legislation, the average lab MELD
score at the time point of transplantation may be re-
duced because outcome will be a major focus of centers
in indicating transplantations [8]. We further propose to
report results from pediatric liver transplant programs
separately from adult liver transplantation. Politicians
and medical representatives are encouraged to explore
an optimal balance between regional supply of medically
underprivileged regions and a reasonable number of
transplant centers delivering the best quality medical
care for the population. This may also include highly
specialized centers that for example focus on complex
treatment of oncologic patients in which a treatment op-
tion is transplantation (model of the Italian Cancer Insti-
tute of Milan). Only by improving outcome through
amending the current system, optimizing patient care
and allocation practice, will society be willing to support
transplant medicine through donations of organs in case
of brain death, as the most critical corner point in this
system.
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